Xiangyu Medical Co.,Ltd (688626.SS)
CNY 34.06
(-4.06%)
CNY 34.06
(-4.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 227.9 Million | 186.7 Million | 165.88 Million | 216.4 Million | 155.94 Million | 74.19 Million |
| Net Income | 228.31 Million | 123.29 Million | 199.53 Million | 196.01 Million | 128.89 Million | 80.32 Million |
| Depreciation & Amortization | 18.08 Million | 16.06 Million | 11.37 Million | 10.77 Million | 9.57 Million | 8.94 Million |
| Deferred income taxes | -7.83 Million | 6.18 Million | -1.53 Million | - | -2.06 Million | -698.6 Thousand |
| Stock-based compensation | 2.83 Million | - | - | - | 3.46 Million | - |
| Change in working capital | -31.25 Million | 52.78 Million | -38.44 Million | 5.08 Million | 14.62 Million | -14.11 Million |
| Other non-cash items | 12.76 Million | -5.43 Million | -6.58 Million | 4.53 Million | 1.45 Million | -958.95 Thousand |
| Investing Cash Flow | -234.54 Million | -178.9 Million | -782.04 Million | -139.4 Million | 189.12 Million | -136.73 Million |
| Investments in PPE | -479.26 Million | -203.07 Million | -133.91 Million | -139.71 Million | -21.06 Million | -7.01 Million |
| Acquisitions | 225.15 Thousand | 4.05 Million | 40.4 Thousand | - | 3931.43 | -24.31 Million |
| Investment purchases | -10.1 Million | -3.27 Million | -14 Million | - | -3.3 Million | 40 Thousand |
| Sales/Maturities of investments | 12 Million | 18.67 Million | 9.02 Million | 274.68 Thousand | 2.25 Million | 2.8 Million |
| Other Investing Activities | 242.58 Million | 4.71 Million | -643.19 Million | 29.38 Thousand | 211.24 Million | -108.24 Million |
| Financing Cash Flow | -58.5 Million | -117.04 Million | 955.12 Million | 48.18 Million | -2.68 Million | 63.34 Million |
| Debt repayment | -72.15 Million | -43 Million | -50 Million | -50 Million | -2.28 Million | -10 Million |
| Dividends payments | -37.81 Million | -59.93 Million | -59.2 Million | -805.76 Thousand | - | -34.44 Thousand |
| Common Stock Repurchased | -25.66 Million | -73.27 Million | - | - | - | - |
| Common Stock Issuance | - | 73.27 Million | -21.08 Million | - | - | - |
| Other Financing Activities | -20.89 Million | -13.91 Million | 1.01 Billion | 48.99 Million | -397 Thousand | 73.37 Million |
| Accounts receivables | -44.13 Million | 18.03 Million | -31.44 Million | -11.76 Million | -4.89 Million | -31.78 Million |
| Accounts payables | 48.39 Million | 94.36 Million | 23.84 Million | 11.76 Million | 33.94 Million | 42.82 Million |
| Inventory | -27.68 Million | -65.8 Million | -29.31 Million | 12.67 Million | -12.37 Million | -24.45 Million |
| Other working capital | -7.83 Million | 6.18 Million | -1.53 Million | -7.58 Million | -2.06 Million | 10.34 Million |
| Cash at beginning of period | 716.92 Million | 826.18 Million | 487.24 Million | 361.99 Million | 19.66 Million | 18.84 Million |
| Cash at end of period | 651.76 Million | 716.92 Million | 826.18 Million | 487.24 Million | 361.99 Million | 19.66 Million |
| Capital Expenditure | -479.26 Million | -203.07 Million | -133.91 Million | -139.71 Million | -21.06 Million | -7.01 Million |
| Effect of forex changes on cash | -16.49 Thousand | -21.6 Thousand | -21.65 Thousand | 62.01 Thousand | -54.66 Thousand | 9497.46 |
| Net cash flow / Change in cash | -65.15 Million | -109.26 Million | 338.94 Million | 125.24 Million | 342.33 Million | 818.33 Thousand |
| Free Cash Flow | -251.35 Million | -16.37 Million | 31.97 Million | 76.68 Million | 134.87 Million | 67.18 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 16.77 Million | 17.56 Million | 39.07 Million | 47.98 Million | 228.31 Million | 71.54 Million |
| Depreciation & Amortization | - | 10.79 Million | 10.79 Million | 5.19 Million | 18.08 Million | -7.91 Million |
| Deferred income taxes | - | - | - | 66.15 Million | -7.83 Million | - |
| Stock-based compensation | - | 3.33 Million | - | 2.83 Million | 2.83 Million | - |
| Change in working capital | - | -28.07 Million | - | -68.99 Million | -31.25 Million | 12.01 Million |
| Other non-cash items | 43.64 Million | 10.59 Million | -21.77 Million | 5.49 Million | 12.76 Million | -6.95 Million |
| Investing Cash Flow | -107.55 Million | 48.29 Million | -129.82 Million | 10.42 Million | -234.54 Million | -112.72 Million |
| Investments in PPE | -107.56 Million | -118.72 Million | -125.9 Million | -94.23 Million | -479.26 Million | -156.27 Million |
| Acquisitions | - | 13 Thousand | - | 312.59 Thousand | 225.15 Thousand | 466 Million |
| Investment purchases | 159 Million | -159 Million | - | -103 Thousand | -10.1 Million | -466 Million |
| Sales/Maturities of investments | 8865.37 | 321 Million | 1.08 Million | 4.45 Million | 12 Million | 552.16 Thousand |
| Other Investing Activities | - | 59 Million | -4.99 Million | 100 Million | 242.58 Million | 42.99 Million |
| Financing Cash Flow | 107.55 Million | -161.46 Million | 205.13 Million | -207.85 Million | -58.5 Million | 52.46 Million |
| Debt repayment | -54.98 Million | -39.99 Million | -157 Million | -17.15 Million | -72.15 Million | -126 Million |
| Dividends payments | -756.84 Thousand | -84.4 Million | -21.25 Thousand | -1.15 Million | -37.81 Million | -798.31 Thousand |
| Common Stock Repurchased | 56.69 Million | -56.69 Million | - | -25.66 Million | -25.66 Million | 6.96 Million |
| Common Stock Issuance | - | - | - | - | - | 119.03 Million |
| Other Financing Activities | 53.32 Million | -144.76 Million | 48.16 Million | -189.54 Million | -20.89 Million | 53.26 Million |
| Accounts receivables | - | -24.31 Million | - | -44.13 Million | -44.13 Million | 254.57 Thousand |
| Accounts payables | - | - | - | - | 48.39 Million | - |
| Inventory | - | -3.76 Million | - | -27.68 Million | -27.68 Million | 11.75 Million |
| Other working capital | - | - | - | 2.83 Million | -7.83 Million | - |
| Cash at beginning of period | 648.57 Million | 758.93 Million | 651.76 Million | 790.45 Million | 716.92 Million | 782 Million |
| Cash at end of period | 709.12 Million | 674.34 Million | 744.37 Million | 651.76 Million | 651.76 Million | 790.45 Million |
| Capital Expenditure | -107.56 Million | -118.72 Million | -125.9 Million | -94.23 Million | -479.26 Million | -156.27 Million |
| Effect of forex changes on cash | 128.99 Thousand | 3148.35 | -7054.59 | 69.43 Thousand | -16.49 Thousand | 13.55 Thousand |
| Net cash flow / Change in cash | 60.55 Million | -84.58 Million | 92.6 Million | -138.68 Million | -65.15 Million | 8.44 Million |
| Free Cash Flow | -47.13 Million | -101.34 Million | -108.61 Million | -35.56 Million | -251.35 Million | -87.58 Million |
7649
6915
3080
KFH
DADA
SSF